BEATW on Nasdaq

HeartBeam, Inc.

HeartBeam is a medical technology company focused on transforming cardiac care through the power of personalized insights.³ From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

TickerBEATW on Nasdaq¹
IndustrySurgical & Medical Instruments & Apparatus¹
HeadquartersSanta Clara, California¹
Incorporated inDE²
Business address2118 Walsh Ave., Suite 210, Santa Clara, Ca 95050²
Filer category, Emerging growth company²

See how the biggest companies compare on our leaderboards

HeartBeam is a medical technology company focused on transforming cardiac care through the power of personalized insights. Our aim is to deliver innovative, higher resolution ambulatory cardiac monitoring solutions that can be used by patients anywhere to enable the detection and monitoring of cardiac disease outside of a healthcare facility. Our ability to develop higher resolution Electrocardiogram (“ECG”) solutions is achieved through the development of our proprietary and patented technology platform that allows us to collect the heart’s electrical activity from three dimensions and synthesize a 12-Lead (“12L”) ECG from these signals.³ From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income⁴⁵⁶⁷⁸-$21.1M in 2025+2583% since 2020

Net income⁴⁵⁶⁷⁸-$21.0M in 2025+1868% since 2020

Every line of the income statement as filed: the last 2 fiscal years, latest first.⁸

Period ending	2025-12-31	2024-12-31
General and administrative	$7.7M	$8.8M
Research and development	$13.4M	$11.1M
Total operating expenses	$21.1M	$19.9M
Loss from operations	-$21.1M	-$19.9M
Interest income	$122.0K	$446.0K
Other income and expense (net)	$2.0K	-$7.0K
Total other income	$124.0K	$439.0K
Loss before provision for income taxes	-$21.0M	-$19.4M
Income tax provision	$0	$0
Net Loss	-$21.0M	-$19.4M
Net loss per share, basic (in dollars per share)	-$0.62	-$0.73
Net loss per share, diluted (in dollars per share)	-$0.62	-$0.73
Weighted average common shares outstanding, basic (in shares)	33.7M shares	26.6M shares
Weighted average common shares outstanding, diluted (in shares)	33.7M shares	26.6M shares

Total assets⁴⁵⁶⁷⁸$5.8M in 2025+11357% since 2020

Total liabilities⁴⁵⁶⁷⁸$3.2M in 2025−33% since 2020

Shareholders’ equity⁴⁵⁶⁷⁸$2.6M in 2025

Cash⁴⁵⁶⁷⁸$4.4M in 2025+87500% since 2019

Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.⁸

Period ending	2025-12-31	2024-12-31	2023-12-31
Cash and cash equivalents	$4.4M	$2.4M
Prepaid expenses and other current assets	$202.0K	$393.0K
Inventory	$103.0K	$0
Total Current Assets	$4.7M	$2.8M
Property and equipment, net	$1.1M	$450.0K
Other assets	$56.0K	$56.0K
Total Assets	$5.8M	$3.3M
Accrued expenses	$2.2M	$1.1M
Total Liabilities	$3.2M	$1.6M
Preferred Stock - $0.0001 par value; 10,000,000 shares authorized; 0 shares outstanding at December 31, 2025 and 2024	$0	$0
Common stock - $0.0001 par value; 100,000,000 shares authorized; 40,117,404 and 26,960,901 shares issued and outstanding at December 31, 2025 and 2024	$4.0K	$3.0K
Additional paid in capital	$79.9M	$57.9M
Accumulated deficit	-$77.3M	-$56.3M
Total Stockholders Equity	$2.6M	$1.7M	$15.9M
Total Liabilities and Stockholders Equity	$5.8M	$3.3M
Due to related party	$1.1M	$531.0K
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in shares)	10.0M shares	10.0M shares
Preferred stock, shares outstanding (in shares)	0 shares	0 shares
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized (in shares)	100.0M shares	100.0M shares
Common stock, shares issued (in shares)	40.1M shares	40.1M shares
Common stock, shares outstanding (in shares)	27.0M shares	27.0M shares

Period ending	2025-12-31	2024-12-31	2023-12-31
Cash and cash equivalents	$4.4M	$2.4M
Prepaid expenses and other current assets	$202.0K	$393.0K
Inventory	$103.0K	$0
Total Current Assets	$4.7M	$2.8M
Property and equipment, net	$1.1M	$450.0K
Other assets	$56.0K	$56.0K
Total Assets	$5.8M	$3.3M
Accrued expenses	$2.2M	$1.1M
Total Liabilities	$3.2M	$1.6M
Preferred Stock - $0.0001 par value; 10,000,000 shares authorized; 0 shares outstanding at December 31, 2025 and 2024	$0	$0
Common stock - $0.0001 par value; 100,000,000 shares authorized; 40,117,404 and 26,960,901 shares issued and outstanding at December 31, 2025 and 2024	$4.0K	$3.0K
Additional paid in capital	$79.9M	$57.9M
Accumulated deficit	-$77.3M	-$56.3M
Total Stockholders Equity	$2.6M	$1.7M	$15.9M
Total Liabilities and Stockholders Equity	$5.8M	$3.3M
Due to related party	$1.1M	$531.0K
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in shares)	10.0M shares	10.0M shares
Preferred stock, shares outstanding (in shares)	0 shares	0 shares
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized (in shares)	100.0M shares	100.0M shares
Common stock, shares issued (in shares)	40.1M shares	40.1M shares
Common stock, shares outstanding (in shares)	27.0M shares	27.0M shares

Cash from operations⁴⁵⁶⁷⁸-$14.0M in 2025+2231% since 2020

Capital spending⁶⁷⁸$600.0K in 2025

Free cash flow⁶⁷⁸-$14.6M in 2025+47% since 2022

Every line of the cash flow as filed: the last 2 fiscal years, latest first.⁸

Period ending	2025-12-31	2024-12-31
Net Income (Loss)	-$21.0M	-$19.4M
Depreciation	$40.0K	$7.0K
Stock-based compensation expense	$5.1M	$4.3M
Stock issuance for services	$226.0K	$0
Prepaid expenses and other current assets	$191.0K	$243.0K
Inventory	-$103.0K	$0
Accounts payable and accrued expenses	$1.5M	$428.0K
Net cash used in operating activities	-$14.0M	-$14.5M
Purchase of property and equipment	-$600.0K	-$201.0K
Purchase of short-term investments	$3.8M	$0
Maturities of short-term investments	-$3.8M	$0
Net cash used in investing activities	-$600.0K	-$201.0K
Proceeds from exercise of stock options	$13.0K	$136.0K
Net cash provided by financing activities	$16.6M	$866.0K
Net increase (decrease) in cash and restricted cash	$2.0M	-$13.8M
Purchase of property and equipment in accounts payable	$92.0K	$0
Taxes paid	$0	$0

Compare HeartBeam, Inc. with another company

Leadership

Who has led HeartBeam, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

Chief operating officer

Alan Baumel2021–2022

2025

Chief executive officerRobert Paul Eno May 1, 2025 to now¹¹
Chief executive officerBranislav Vajdic Nov 12, 2021 to May 1, 2025¹²
PresidentBranislav Vajdic May 1, 2025 to now¹³
PresidentRobert Paul Eno Jan 27, 2023 to May 1, 2025¹⁴
Chief financial officerTim Cruickshank Sep 20, 2024 to now¹⁵
Chief financial officerRichard D. Brounstein Nov 12, 2021 to Feb 14, 2023¹⁶
Chief operating officerAlan Baumel Dec 23, 2021 to Jun 17, 2022¹⁷

Board members and other officers (10)

Chief Technology OfficerKenneth Harry Persen Aug 12, 2022 to now¹⁸
Exec Chm of the BODRichard M. Ferrari Nov 12, 2021 to Nov 12, 2021¹⁹
Board memberMark E. Strome Apr 16, 2026 to now²⁰
Board memberBranislav Vajdic May 1, 2025 to now¹³
Board memberKenneth Warwick Nelson Iii. Jun 15, 2023 to now²¹
Board memberMichael R. Jaff Aug 2, 2023 to now²²
Board memberMarga Ortigas-Wedekind Nov 12, 2021 to now²³
Board memberRichard M. Ferrari Nov 12, 2021 to now¹⁹
Board memberWillhem Elfrink Nov 12, 2021 to now²⁴
Board memberUrioste George De Nov 15, 2021 to now²⁵

Timeline

May 1, 2025New chief executive Robert Paul Eno becomes CEO¹¹
Nov 12, 2021New chief executive Branislav Vajdic becomes CEO¹²

Filings

262 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 41 major events, 131 insider forms, 10 large holders, 60 other. The latest 20:

Oct 9, 20264 EDGAR
Oct 9, 20264 EDGAR
Oct 9, 20264 EDGAR
Oct 9, 20264 EDGAR
Oct 9, 20264 EDGAR
Oct 9, 20264 EDGAR
Aug 14, 20268-K CURRENT REPORT EDGAR
Aug 14, 2026424B5 PROSPECTUS SUPPLEMENT EDGAR
Aug 13, 2026SCHEDULE 13D/A EDGAR
Aug 13, 202610-Q EDGAR
Aug 6, 20268-K/A AMENDMENT NO. 1 TO FORM 8-K EDGAR
Aug 3, 20268-K CURRENT REPORT EDGAR
Jul 24, 20264 OWNERSHIP DOCUMENT EDGAR
Jul 24, 20264 OWNERSHIP DOCUMENT EDGAR
Jul 24, 20264 OWNERSHIP DOCUMENT EDGAR
Jul 2, 20268-K CURRENT REPORT EDGAR
Jun 25, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR
Jun 24, 20268-K CURRENT REPORT EDGAR
Jun 22, 20268-K CURRENT REPORT EDGAR
Jun 18, 2026DEF 14A EDGAR

The 262 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

33 open-market trades by officers, directors and large owners since October 2021: 14 buys and 19 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
Apr 16, 2026	Ferrari RichardDirector	Buy	57,500	$0.80	$46.0K	Form 4
Apr 16, 2026	Cruickshank TimCFO	Buy	31,250	$0.80	$25.0K	Form 4
Apr 16, 2026	Elfrink WillemDirector	Buy	187,500	$0.80	$150.0K	Form 4
Apr 16, 2026	JAFF MICHAEL RDirector	Buy	31,250	$0.80	$25.0K	Form 4
Apr 16, 2026	Vajdic BranislavPresident	Buy	31,250	$0.80	$25.0K	Form 4
Apr 16, 2026	Ferrari RichardDirector	Buy	62,500	$0.80	$50.0K	Form 4
Apr 16, 2026	ENO Robert PaulPresident	Buy	12,500	$0.80	$10.0K	Form 4
Apr 16, 2026	Ortigas-Wedekind MargaDirector	Buy	25,000	$0.80	$20.0K	Form 4
Apr 16, 2026	STROME MARK EDirector	Buy	750,000	$0.80	$600.0K	Form 4
Dec 18, 2025	de Urioste GeorgeDirector	Sale	33,185	$2.83	$93.9K	Form 4
Dec 17, 2025	STROME MARK EDirector	Sale	250,000	$3.58	$895.0K	Form 4
Dec 17, 2025	de Urioste GeorgeDirector	Sale	23,961	$3.68	$88.2K	Form 4
Feb 14, 2025	Ferrari RichardDirector	Buy	29,412	$1.70	$50.0K	Form 4
Feb 14, 2025	Cruickshank TimCFO	Buy	17,647	$1.70	$30.0K	Form 4
Sep 6, 2024	de Urioste GeorgeDirector	Sale	1,674	$2.34	$3.9K	Form 4
Aug 30, 2024	de Urioste GeorgeDirector	Sale	5,500	$2.31	$12.7K	Form 4
Aug 27, 2024	de Urioste GeorgeDirector	Sale	2,194	$2.26	$5.0K	Form 4
Aug 26, 2024	de Urioste GeorgeDirector	Sale	300	$2.38	$714	Form 4
Aug 23, 2024	de Urioste GeorgeDirector	Sale	2,500	$2.30	$5.8K	Form 4
Sep 29, 2023	de Urioste GeorgeDirector	Sale	5,500	$2.06	$11.3K	Form 4

All 33 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Mark E. StromeSCHEDULE 13D/A, 2 filings Oct 25, 2023 to Aug 13, 2026²⁶
PUBLIC VENTURES, LLCSC 13D, 1 filing Aug 28, 2023²⁷
Andrew SchwartzbergSC 13D, 1 filing Jun 2, 2023²⁸
Ionic Ventures, LLCSC 13G/A, 3 filings Nov 16, 2021 to Feb 13, 2023²⁹
SABBY MANAGEMENT, LLCSC 13G/A, 3 filings Nov 17, 2021 to Jan 10, 2023³⁰

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
Armistice Capital, LLC	500,000	$14.0K	0.0%	No change
Clear Street Group Inc.	16,611	$465	0.0%	No change
D'Orazio & Associates, Inc.	16,000	$453	0.0%	No change
Two Sigma Securities, LLC	11,653	$330	0.0%	−246
Wells Fargo & Company/mn	7,500	$210	0.0%	No change
UBS Group AG	3,837	$107	0.0%	+1,880

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHeartBeam, Inc. filings on SEC EDGAR
2
SEC EDGARHeartBeam, Inc. filings on SEC EDGAR
3
SEC EDGARHeartBeam, Inc. annual report, Item 1 (Business)
4
SEC EDGARHeartBeam, Inc. 10-K for fiscal 2020
5
SEC EDGARHeartBeam, Inc. 10-K for fiscal 2021
6
SEC EDGARHeartBeam, Inc. 10-K for fiscal 2022
7
SEC EDGARHeartBeam, Inc. 10-K for fiscal 2023
8
SEC EDGARHeartBeam, Inc. 10-K for fiscal 2024
9
SEC EDGARHeartBeam, Inc. 10-Q for fiscal 2026
10
SEC EDGARHeartBeam, Inc. 10-Q for fiscal 2026
11
SEC EDGARRobert Paul Eno, Chief executive officer
12
SEC EDGARBranislav Vajdic, Chief executive officer
13
SEC EDGARBranislav Vajdic, President
14
SEC EDGARRobert Paul Eno, President
15
SEC EDGARTim Cruickshank, Chief financial officer
16
SEC EDGARRichard D. Brounstein, Chief financial officer
17
SEC EDGARAlan Baumel, Chief operating officer
18
SEC EDGARKenneth Harry Persen, Chief Technology Officer
19
SEC EDGARRichard M. Ferrari, Exec Chm of the BOD
20
SEC EDGARMark E. Strome, Board member
21
SEC EDGARKenneth Warwick Nelson Iii., Board member
22
SEC EDGARMichael R. Jaff, Board member
23
SEC EDGARMarga Ortigas-Wedekind, Board member
24
SEC EDGARWillhem Elfrink, Board member
25
SEC EDGARUrioste George De, Board member
26
SEC EDGARMark E. Strome SCHEDULE 13D/A on HeartBeam, Inc.
27
SEC EDGARPUBLIC VENTURES, LLC SC 13D on HeartBeam, Inc.
28
SEC EDGARAndrew Schwartzberg SC 13D on HeartBeam, Inc.
29
SEC EDGARIonic Ventures, LLC SC 13G/A on HeartBeam, Inc.
30
SEC EDGARSABBY MANAGEMENT, LLC SC 13G/A on HeartBeam, Inc.